ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

2018 ACR/ARHP Annual Meeting

October 19-24, 2018. Chicago, IL.

View by Number View by Title View Sessions
View by Date

Sunday, October 21, 2018

9:00AM-11:00AM
Abstract Number: 763
Comparison of Clinical Characteristics and Outcome between Isolated and Classic Lupus Nephritis
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity
9:00AM-11:00AM
Abstract Number: 759
Comparison of Length of Stay and Total Hospital Charges for Hospitalizations for Sepsis in Patients with Systemic Lupus Erythematosus: A Study of National Inpatient Sample Database 2010 to 2014
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity
9:00AM-11:00AM
Abstract Number: 56
Comparison of Metabolic Changes in Osteoarthritis and Rheumatoid Arthritis Mouse Models
Rheumatoid Arthritis – Animal Models Poster
9:00AM-11:00AM
Abstract Number: 659
Comparison of MRI and Conventional Radiography for Detection of Structural Changes Typical for Spa – Data from the Assessment of Spondyloarthritis International Society Cohort
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment
9:00AM-11:00AM
Abstract Number: 786
Comparison of Nailfold Microvascular Damage in Mixed Connective Tissue Disease Versus Systemic Sclerosis Patients during a Three Year Follow-up
Systemic Sclerosis and Related Disorders – Clinical Poster I
9:00AM-11:00AM
Abstract Number: 414
Comparison of Physical Activity Measures Derived from the Fitbit Flex and the Actigraph GT3x+ in an Employee Population with Chronic Knee Symptoms
Orthopedics, Low Back Pain and Rehabilitation Poster – ACR/ARHP
9:00AM-11:00AM
Abstract Number: 403
Comparison of Radial Extracorporeal Shock Wave Therapy and Traditional Physiotherapy in Rotator Cuff Calcific Tendinitis Treatment
Orthopedics, Low Back Pain and Rehabilitation Poster – ACR/ARHP
9:00AM-11:00AM
Abstract Number: 287
Comparison of Real-World Costs between Patients with Rheumatoid Arthritis Treated with Subcutaneously-Administered Biologics Previously Treated with Another Biologic
Health Services Research Poster I – ACR/ARHP
9:00AM-11:00AM
Abstract Number: 332
Components of Impaired Physical Function and Disability in a Non-Rheumatic Population. Normative Values of the Health Assessment Questionnaire Disability Index
Measures and Measurement of Healthcare Quality Poster I
9:00AM-11:00AM
Abstract Number: 16
Comprehensive Antibody Profiling Using High Density Peptide Arrays Reveals Novel Citrullinated Protein Targets in Rheumatoid Arthritis Serum Samples
B Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster
9:00AM-11:00AM
Abstract Number: 658
Construct Validation of the Screening for Inflammatory Pain in the Lower Back Questionnaire: Data from the Screening in Axial Spondyloarthritis in Psoriasis, Iritis, and Colitis Cohort
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment
9:00AM-11:00AM
Abstract Number: 641
Construct Validity of the Swollen and Tender Joint Counts for the Measurement of MSK Disease Activity in Psoriatic Arthritis
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment
9:00AM-11:00AM
Abstract Number: 751
Coronary Plaque Burden in Patients with Lupus Compared to Healthy Volunteers
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity
9:00AM-11:00AM
Abstract Number: 483
Correlation between Disease Activity and Hip Score in Patients with Rheumatoid Arthritis after Total Hip Arthroplasty
Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster I: Comorbidities
9:00AM-11:00AM
Abstract Number: 785
Correlation between Nailfold Capillary Number and Blood Perfusion in Systemic Lupus Erythematosus Patients
Systemic Lupus Erythematosus – Clinical Poster I: Clinical Manifestations and Comorbidity
  • «Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 67
  • Next Page»
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology